LEVODOPA
C16452
http://purl.bioontology.org/ontology/NDFRT/C16452
Glaucoma, Angle-Closure
Drug Hypersensitivity
Melanoma
Monoamine Oxidase Inhibitors
Levodopa
Dopamine Receptor Interactions
Increased Central Nervous System Dopamine Activity
Ingredient
Parkinson Disease
NDF_KIND
N0000146151
L [Preparations]
CARBIDOPA 25MG/LEVODOPA 250MG TAB
CARBIDOPA 25MG/LEVODOPA 100MG TAB,UD
CARBIDOPA 10MG/LEVODOPA 100MG TAB,RAPID DISINTEGRATING
CARBIDOPA 12.5MG/ENTACAPONE 200MG/LEVODOPA 50MG TAB
CARBIDOPA 10MG/LEVODOPA 100MG TAB,UD
CARBIDOPA 10MG/LEVODOPA 100MG TAB
LEVODOPA 100MG CAP
CARBIDOPA 25MG/LEVODOPA 100MG TAB,SA,UD
LEVODOPA 100MG TAB
LEVODOPA 250MG TAB
CARBIDOPA 25MG/LEVODOPA 100MG TAB,SA
CARBIDOPA 25MG/LEVODOPA 250MG TAB,RAPID DISINTEGRATING
LEVODOPA 500MG TAB
CARBIDOPA 25MG/LEVODOPA 100MG TAB
LEVODOPA 250MG CAP
LEVODOPA 500MG CAP
CARBIDOPA 25MG/ENTACAPONE 200MG/LEVODOPA 100MG TAB
CARBIDOPA 50MG/LEVODOPA 200MG TAB,SA
CARBIDOPA 25MG/LEVODOPA 100MG TAB,RAPID DISINTEGRATING
CARBIDOPA 37.5MG/ENTACAPONE 200MG/LEVODOPA 150MG TAB
CARBIDOPA 25MG/LEVODOPA 250MG TAB,UD
6375
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Neuroreactive Substance or Biogenic Amine
C0023570
True
4017790